Skip to main content
search

Late Clinical

Sign up

Latest resources

Featured resource

Upcoming late clinical webinars

Webinar

Certara IQ™: The Scalable AI-Powered QSP Software

October 30, 2025 – 10 am ET
Webinar

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

US (ET): Thursday, November 6, 11:00am – 11:30am EMEA (GMT): Thursday, November 13, 10:00am – 10:30am APAC (JST): Thursday, November

Latest late clinical blogs

Meet our experts at the following events

Conference

AAPS 2025 PharmSci 360

November 9 - 12, 2025
Conference

PHUSE EU Connect

November 16 - 19, 2025 – Hamburg, Germany
Conference

JSCPT 2025 – The 46th Annual Scientific Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics

We’re excited to participate in JSCPT 2025 in Tokyo, The 46th Annual Scientific Meeting of The Japanese Society of Clinical

All late clinical resources

Key Lessons & Opportunities in applying NCA and PopPK to ADCs

Biologics, Certara Services, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Pharmacometrics, Blog

Bottlenecks to Breakthroughs: Tackling Challenges in QSP Modeling

Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - QSP, Blog

Pregnant women, long excluded from drug trials, are back in the spotlight

Certara Products - Simcyp, Modeling and Simulation - PBPK, Press Coverage

Streamlining PK/PD Reporting: A Smarter Approach to Generating Tables, Figures and Listings

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, Blog

Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results

Certara Products, Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Publication

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

Drug Development, Modeling and Simulation, Webinar

Certara IQ™ Fact Sheet

Modeling and Simulation - QSP, Quantitive Systems Pharmacology (QSP), Fact Sheet

Essentials of Model-informed Drug Development in Oncology

Certara Products - Simcyp, Modeling and Simulation - PBPK, Pharmacometrics, Quantitive Systems Pharmacology (QSP), Blog

Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Therapeutic Specialties, Case Study

Certara University: Introducing Certara’s Phoenix Cloud TFL Studio: Streamlined Creation of Tables, Figures & Listings

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, Webinar

Best Practices in Clinical Pharmacology Gap Analysis

Certara Services, Clinical Pharmacology, Modeling and Simulation, Blog

What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?

Biologics, Cell and Gene Therapy, Certara Services, Therapeutic Specialties, Press Coverage
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.